CD19 and acute lymphoblastic leukemia: Afterward, another report showed 2 of 7 patients with mixed lineage leukemia (MLL)-rearranged B-ALL and in a case report of a pediatric B-ALL, relapsing with CD19-negative AML after CD19 CAR T-cell therapy [129, 130].